1.
Simioni C, Ultimo S, Martelli AM, Zauli G, Capitani S, Neri LM. Synergistic effects of selective inhibitors targeting the PI3K/AKT/mTOR pathway and NUP214-ABL1 fusion protein in human acute lymphoblastic leukemia. Ital J Anat Embryol [Internet]. 2017 Oct. 6 [cited 2024 Nov. 25];121(1):127. Available from: https://oajournals.fupress.net/index.php/ijae/article/view/2265